The U.S. government has reached a $1.95 billion deal with Pfizer and BioNTech for 100 million doses of their experimental COVID-19 vaccine after it receives regulatory approval from the Food and Drug Administration.
Stocks shake off US-China tensions, focus on coronavirus vaccine progress
Leave a reply
Foreaders 